Hengkang Medical Group Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hengkang Medical Group Co Ltd with three other
companies in this sector in China:
Guizhou Yibai Pharmaceutical Co., Ltd.
sales of 3.88 billion Chinese Renmimbi [US$552.88 million]
of which 77%
was Medical Industry),
Cisen Pharmaceutical Co Ltd
(3.80 billion Chinese Renmimbi [US$541.70 million]
of which 55%
was Large infusion), and
Jiangsu Kanion Pharmaceutical Co., Ltd.
(3.82 billion Chinese Renmimbi [US$544.47 million]
of which 100%
was Domestic Sales of Industrial Enterprises).
Hengkang Medical Group Co Ltd reported sales of 3.84 billion Chinese Renmimbi (US$546.55 million)
December of 2018.
increase of 12.9%
versus 2017, when the company's sales were 3.40 billion Chinese Renmimbi.
Sales at Hengkang Medical Group Co Ltd have increased during each of the previous five years
(and since 2013, sales have increased a total of 580%).